Conference abstractPublished 2018
Assessing the quality of antimalarial drugs from India using minilab: A field study
National Institute of Malaria Research, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Substandard and counterfeit antimalarial medicines pose a serious threat to public health. These counterfeit/ substandard medicines increase the mortality by decreasing efficacy; it also increases the threat of emergence of drug resistance, adverse effect from incorrect excipients/ active ingredients which may be potentially dangerous to the patients. Owing to this, a pilot study was conducted to survey quality of drugs collected from different malaria endemic areas of India. The survey was conducted in different geographical regions on the basis of malaria endemicity i.e. Uttar Pradesh (U.P.), Mizoram, Meghalaya, Gujarat, Madhya Pradesh. Antimalarial samples of ACT (Artesunate+Sulphadoxine-pyremethamine), (Artesunate + Lumefantrine), Chloroquine, Primaquine were collected for qualitative analysis. A mystery shopper approach was used for collection of samples. The quality of antimalarial drugs from these areas was assessed by using Global Pharma Health Fund Minilab test kit. This includes physical/visual inspection and disintegration test, thin-layer chromatography. High performance liquid chromatography was carried out for quantitative assessment of active pharmaceutical ingredient. A total of 150 antimalarial samples were collected. These samples includes 55 (Chloroqunie), 50 (Artemether Lumefantrine), 14 (Artesunate Sulphadoxine-Pyrimethamine), 31 (Primaquine). These samples were assessed by quality using GPHF minilab lab kit. In this study 98% of the tablets passed minilab disintegration, 2% consisting did not passed disintegration test. 99% of samples passed preliminary Qualitative TLC test when compared with 100% and 80% of the standards. 96% of samples passed quantitative HPLC test, 4% of samples (contained low active pharmaceutical ingredient) did not passed this test. The substandard drugs circulating in the market causes drug resistance, treatment failure and finally leads to death. Additional analysis such as post-marketing surveillance should be done so that good quality antimalarials reached to the population.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Medical Biotechnology
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Taruna Katyal Arora”
- BylineArticles whose byline prints “Neena Valecha”
